How are ApoB and Schlaf related?

Apolipoprotein B (ApoB) is the primary structural protein of atherogenic lipoproteins (LDL, VLDL, IDL, Lp(a)) and is considered a more accurate marker of cardiovascular risk than LDL cholesterol alone. Sleep influences ApoB metabolism through several pathways: chronic sleep restriction or disorders (e.g., sleep apnea) can increase hepatic VLDL secretion, reduce clearance of ApoB-containing particles, and thus raise ApoB levels. Additionally, sleep deprivation promotes insulin resistance and low-grade inflammation, further driving ApoB production. Conversely, adequate, high-quality sleep improves lipid profiles. However, the evidence is largely observational; causal mechanisms are not fully established. Single biomarkers like ApoB should therefore be interpreted within the context of overall lifestyle. An ApoB test alone does not replace medical diagnosis but can be useful as part of a comprehensive risk assessment.